These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23057797)

  • 1. Liver defatting: an alternative approach to enable steatotic liver transplantation.
    Nativ NI; Maguire TJ; Yarmush G; Brasaemle DL; Henry SD; Guarrera JV; Berthiaume F; Yarmush ML
    Am J Transplant; 2012 Dec; 12(12):3176-83. PubMed ID: 23057797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers.
    Taba Taba Vakili S; Kailar R; Rahman K; Nezami BG; Mwangi SM; Anania FA; Srinivasan S
    Liver Transpl; 2016 Apr; 22(4):459-67. PubMed ID: 26714616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
    Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
    Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothermic oxygenated perfusion with defatting cocktail further improves steatotic liver grafts in a transplantation rat model.
    Lin F; Zhen F; Yan X; Shaojun Y; Guizhu P; Yanfeng W; Qifa Y
    Artif Organs; 2021 Sep; 45(9):E304-E316. PubMed ID: 33908066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver in liver transplantation and surgery.
    Selzner M; Clavien PA
    Semin Liver Dis; 2001; 21(1):105-13. PubMed ID: 11296690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defatting of Human Livers During Long-Term e x situ Normothermic Perfusion: Novel Strategy to Rescue Discarded Organs for Transplantation.
    Sousa Da Silva RX; Bautista Borrego L; Lenggenhager D; Huwyler F; Binz J; Mancina L; Breuer E; Wernlé K; Hefti M; Mueller M; Cunningham L; De Oliveira ML; Petrowsky H; Weber A; Dutkowski P; Hoffmann W; Gupta A; Tibbitt MW; Humar B; Clavien PA
    Ann Surg; 2023 Nov; 278(5):669-675. PubMed ID: 37497663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.
    Nativ NI; Yarmush G; So A; Barminko J; Maguire TJ; Schloss R; Berthiaume F; Yarmush ML
    Liver Transpl; 2014 Aug; 20(8):1000-11. PubMed ID: 24802973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
    Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
    Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFD assessment of the effect of convective mass transport on the intracellular clearance of intracellular triglycerides in macrosteatotic hepatocytes.
    Yarmush G; Santos L; Yarmush J; Koundinyan S; Saleem M; Nativ NI; Yarmush ML; Berthiaume F; Maguire TJ; Guaghan C
    Biomech Model Mechanobiol; 2017 Aug; 16(4):1095-1102. PubMed ID: 28220319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review.
    Boteon YL; Boteon APCS; Attard J; Mergental H; Mirza DF; Bhogal RH; Afford SC
    Am J Transplant; 2018 Oct; 18(10):2384-2399. PubMed ID: 29947472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
    Gehrau RC; Mas VR; Dumur CI; Suh JL; Sharma AK; Cathro HP; Maluf DG
    Transplantation; 2015 Dec; 99(12):2523-33. PubMed ID: 26285018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
    Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
    Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
    Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
    Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
    Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
    Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.
    Nagrath D; Xu H; Tanimura Y; Zuo R; Berthiaume F; Avila M; Yarmush R; Yarmush ML
    Metab Eng; 2009; 11(4-5):274-83. PubMed ID: 19508897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery.
    Boteon YL; Attard J; Boteon APCS; Wallace L; Reynolds G; Hubscher S; Mirza DF; Mergental H; Bhogal RH; Afford SC
    Liver Transpl; 2019 Jul; 25(7):1007-1022. PubMed ID: 30821045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.